White House withdraws FDA nominee Heidi Overton before Senate vote
What's next: The FDA stays under temporary leadership as Democrats prepare to take Senate control in January.
The Trump administration withdrew Heidi Overton’s nomination to run the Food and Drug Administration before a Senate committee vote, Axios reported, citing a senior administration official. The move leaves the FDA without a permanent commissioner at a time of continued leadership turnover at the agency. Overton, a White House domestic policy aide, had faced resistance from Republicans including Senator Bill Cassidy, who criticized her role in a Trump executive order on childhood vaccinations. Senators Susan Collins and Lisa Murkowski had also raised concerns tied to FDA actions on flavored vapes and the abortion pill mifepristone. Kyle Diamantas is leading the agency on a temporary basis.